Cytox Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cytox Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10826
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict that patients with MCI will develop Alzheimer’s disease. Its biomarkers are based on the cell cycle hypothesis of Alzheimer’s disease discovered. Cytox offers Cytox variatech SNP research assay that is a biomarker research assay to reduce screening failure in clinical trials and helps in novel drug discovery. The company also provides biomarker services to pharmaceutical industry clients to conduct clinical trials with drugs for the treatment of Alzheimer’s disease and mild cognitive impairment. It partners with pharmaceutical industry and academic researchers to develop blood-based assays. Cytox is headquartered in Oxford, the UK.

Cytox Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cytox Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Cytox Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cytox Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cytox Raises USD3.3 Million in Venture Financing 11
Partnerships 13
Cytox Expands Research Agreement with AIBL 13
Licensing Agreements 14
Alta Innovations Enters Into Licensing Agreement With Cytox 14
Cytox Ltd – Key Competitors 15
Cytox Ltd – Key Employees 16
Cytox Ltd – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Cytox Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Cytox Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Cytox Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cytox Raises USD3.3 Million in Venture Financing 11
Cytox Expands Research Agreement with AIBL 13
Alta Innovations Enters Into Licensing Agreement With Cytox 14
Cytox Ltd, Key Competitors 15
Cytox Ltd, Key Employees 16

List of Figures
Cytox Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cytox Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cytox Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cytox Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Cytox Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magellan Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Magellan Diagnostics Inc (Magellan Diagnostics), formerly ESA Inc, a subsidiary of Meridian Bioscience Inc, is a medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services. The company’s products include LeadCare II, LeadCa …
  • NCI, Inc. (NCIT):企業の財務及び戦略的SWOT分析
    Summary NCI, Inc. (NCI) is a technology company that provides engineering, logistics, and professional services and solutions, program management, acquisition and lifecycle support. The company’s enterprise systems management services include infrastructure operations and management, outsourcing and …
  • CooperSurgical Inc:医療機器:M&Aディール及び事業提携情報
    Summary CooperSurgical Inc (CooperSurgical), a subsidiary of The Cooper Companies Inc is a medical device company that offers surgical instrument. The company offers surgical products, clinic and office products, labor and delivery products, and critical care products. Its surgical products include …
  • Plaza Create Co., Ltd. (7502):企業財務及び戦略的SWOT分析
    Summary Plaza Create Co., Ltd. (Plaza Create) is a photo finishing service provider that offers services in development and finishings of photographs and videos. The company provides printing and imaging product such as grasys ID card printer, plaza create D series and qlix digital cameras. Its gras …
  • Bollore S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bollore S.A. Mergers and Acquis …
  • Berliner Volksbank eG:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Berliner Volksbank eG" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly fol …
  • Sysmex America, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Sysmex America, Inc. (Sysmex America), a subsidiary of Sysmex Corporation is a medical device company that manufactures laboratory products. The company's products include clinical diagnostic devices, hematology devices, urinalysis devices, information system, hemostasis devices, harmonized …
  • Sanlam Limited:企業の戦略・SWOT・財務分析
    SummarySanlam Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Blackbird Energy Inc (BBI):企業のM&A・提携動向(石油・ガス分野)
    Summary Blackbird Energy Inc (Blackbird Energy) is an oil and gas company that explores, develops and produces oil and natural gas in Western Canada. The company holds interest in Elmworth Project, which concentrates on the liquids-rich Montney fairway resource near Grande Prairie, Alberta. The comp …
  • Volkswind GmbH:企業の戦略的SWOT分析
    Volkswind GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Biomatrica, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Biomatrica, Inc. Mergers and Ac …
  • Trillium Therapeutics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Trillium Therapeutics, Inc. Mer …
  • Ageas N.V.:企業の戦略・SWOT・財務分析
    SummaryAgeas N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - D …
  • Shenzhen Auto Electric Power Plant Co., Ltd. (002227):企業の財務及び戦略的SWOT分析
    Summary Shenzhen Auto Electric Power Equipment Co., Ltd. (Auto Motion) is an energy equipment company that researches, develops and manufactures electric automatic power supply equipment. The company’s products include electric vehicle charging equipment, AC-DC power equipment, nuclear safety AC-DC …
  • CardiAQ Valve Technologies, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary CardiAQ Valve Technologies, Inc. (CardiAQ) is a medical device company that develops catheter based valve replacement systems. The company offers transcatheter mitral valve implantation system, which is used as an alternative to open chest surgery for treating mitral regurgitation. CardiAQ's …
  • Varta AG (VAR1):企業の財務・戦略的SWOT分析
    Varta AG (VAR1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Vedanta Ltd:企業の戦略・SWOT・財務情報
    Vedanta Ltd - Strategy, SWOT and Corporate Finance Report Summary Vedanta Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Gaz-Servis Respubliki Bashkortostan (GSRB):企業の財務及び戦略的SWOT分析
    Summary This comprehensive SWOT profile of Gaz-Servis Respubliki Bashkortostan provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Industrial Bank of Korea (24110):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Industrial Bank of Korea" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Terma A/S:企業の戦略・SWOT・財務分析
    SummaryTerma A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - De …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆